đź“‹ FDA Reference
philips sli series linear accelerator
Philips Medical Systems
Summary: The Philips SLI Series Linear Accelerator is a medical device used in radiation therapy to treat cancer. It is primarily used by radiation oncologists in clinical settings to deliver precise doses of radiation to tumors.
FDA Clearance Information
Pathway
510K
Number
K963624 ↗
Decision Date
December 6, 1996
Product Code
IYE
Device Class
Class 2
Evidence
419 studies
The Philips SLI Series Linear Accelerator was cleared through the FDA's 510(k) pathway on December 6, 1996. Manufactured by Philips Medical Systems, it is classified as a Class 2 device under product code IYE.
What It Is
The Philips SLI Series Linear Accelerator is a sophisticated medical device designed to deliver high-energy x-rays or electrons to a patient's tumor. It works by accelerating electrons to create a beam of radiation that can be precisely targeted at cancerous tissues, minimizing damage to surrounding healthy tissues. This technology is crucial in modern radiation therapy, offering customizable treatment plans tailored to individual patient needs.
Clinical Applications
Commonly used in oncology departments, the Philips SLI Series Linear Accelerator is integral to the treatment of various cancers, including breast, prostate, and lung cancer. It is typically utilized in hospital settings or specialized cancer treatment centers. The device is suitable for a wide range of patient populations, from pediatric to geriatric, requiring precise and effective radiation therapy.
Indications for Use
The FDA indications for this device include its use in delivering targeted radiation therapy to patients with cancerous tumors. It is designed to treat conditions where localized radiation can effectively reduce or eliminate tumor growth.
Practical Considerations
Clinicians should consider the specific technical requirements of the Philips SLI Series Linear Accelerator, including room size and shielding needs. Compatibility with existing treatment planning systems and the ability to integrate with other imaging modalities are important factors for effective use.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is the Philips SLI Series Linear Accelerator used for?
It is used for delivering precise radiation therapy to treat cancerous tumors.
What specialties typically use this device?
Radiation oncologists primarily use this device in oncology departments or cancer treatment centers.
What are the FDA-cleared indications?
The device is indicated for use in delivering targeted radiation therapy to patients with cancerous tumors.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.